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background: This study examined the influence of catheter ablation (CA) on the incidence and severity of migraine in atrial fibrillation (AF) 
patients with or without pre-ablation migraine-history.
methods: Thirty-six consecutive AF patients with history of migraine (group 1, 64±8 years, male 78%, 52% paroxysmal AF) and 82 (group 2, 61±10 
years, male 73%, 32% paroxysmal AF) without migraine history undergoing CA were prospectively enrolled. Migraine status was determined by using 
a standard migraine questionnaire (adopted by American Migraine Center) at baseline and 6-month follow-up. Diffusion MRI (dMRI) was performed 
for all at pre- and 24-hour post-procedure. Health related quality of life (QoL) was assessed at baseline and 6 months post-procedure, using Medical 
Outcome Study Short Form-36.
results: At 17 ± 5 months follow-up, only one patient reported new-onset migraine that was experienced during the first week post-ablation 
and was transient and self-resolving. Among the group 1 population, the frequency of migraine was reduced markedly; 25 (70%) patients had no 
migraine during follow-up, 8 (22%) reported <1 episode per month, and only 3 patients (8%) reported to have 2-3 monthly migraine attacks. Also, 
the intensity of pain decreased 5 median scale points [baseline 7 (IQR 4-8) to 2 (0-4) at follow-up, p<0.001], and duration of headache reduced 
from median 8 (IQR 4-15) hours to 0.5 (IQR 0-2) hours (p<0.001). Follow-up dMRI revealed new infarcts in 8.5% (10/118) patients; all were from 
group 2 and none had new-onset migraine. QoL improved significantly in patients with successful ablation, being more pronounced in group 1.
conclusion: Catheter ablation was not associated with new-onset migraine or worsening of the existing migraine status. Rather, it reduced the 
severity and frequency of the headache in majority of patients with pre-existent migraine and improved their QoL significantly. Additionally, new 
infarcts revealed by follow-up MRI were not correlated with migraine.
